0.8PLN
991.50 KPLN
22.48 MPLN
About GENOMED
Sector
Industry
CEO
Anna Boguszewska-Chachulska
Website
Headquarters
Warsaw
Employees (FY)
45
Founded
2007
ISIN
PLGNOMD00024
FIGI
BBG001P21SH4
Genomed SA engages in the provision of medical diagnostic services. It offers DNA analysis and congenital diseases diagnostics based on DNA sequencing for scientific centers, biotechnological companies, and medical institutions. The company was founded by Andrzej Henryk Palucha, Anna Boguszewska-Chachulska, Marek Zagulski, and Iwona Wach on September 5, 2007 and is headquartered in Warsaw, Poland.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of GEN is 29.60 PLN — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NEWCONNECT exchange GENOMED stocks are traded under the ticker GEN.
Yes, you can track GENOMED financials in yearly and quarterly reports right on TradingView.
Like other stocks, GEN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENOMED stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 45.00 employees. See our rating of the largest employees — is GENOMED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENOMED EBITDA is 2.25 M PLN, and current EBITDA margin is 10.00%. See more stats in GENOMED financial statements.